Health Policy最新文献

Private provision of health services in Ukraine: A qualitative exploration of current policy challenges, and considerations for reform 乌克兰私人提供保健服务：对当前政策挑战和改革考虑的定性探讨

IF 3.6 3区医学

Health Policy Pub Date : 2025-05-14 DOI: 10.1016/j.healthpol.2025.105349

Mark Hellowell , Olga Demeshko , Radmyla Hrevtsova , Tomas Roubal , Kateryna Fishchuk , Solomiya Kasyanchuk , Jarno Habicht

{"title":"Private provision of health services in Ukraine: A qualitative exploration of current policy challenges, and considerations for reform","authors":"Mark Hellowell , Olga Demeshko , Radmyla Hrevtsova , Tomas Roubal , Kateryna Fishchuk , Solomiya Kasyanchuk , Jarno Habicht","doi":"10.1016/j.healthpol.2025.105349","DOIUrl":"10.1016/j.healthpol.2025.105349","url":null,"abstract":"<div><h3>Background</h3><div>The role of private healthcare providers (PHPs) in Ukraine has increased, despite the ongoing war. As the Government of Ukraine (GoU) continues health reforms, governance mechanisms for PHPs need further examination.</div></div><div><h3>Objective</h3><div>This study assesses the policy responses to the growth of PHPs in Ukraine, focusing on four key state functions: information generation, regulation, purchasing, and policy-making.</div></div><div><h3>Methods</h3><div>A qualitative approach was used, including interviews and document analysis, to explore the effectiveness of governance frameworks in managing the private healthcare sector.</div></div><div><h3>Results</h3><div>Regulations for PHPs are comprehensive but outdated and require stronger enforcement. The National Health Service of Ukraine (NHSU) has extensive purchasing agreements with PHPs but lacks policies to address equity and efficiency concerns. Many PHPs are not enrolled in the national health information system, limiting the GoU’s ability to make evidence-based policy decisions. Strengthening the requirement for PHPs to enrol in the e-health system is needed, along with improved licensing and contractual specifications. Additionally, policy-making processes are vulnerable to influence by PHPs’ commercial interests, highlighting the need for greater transparency and broader stakeholder engagement.</div></div><div><h3>Conclusions</h3><div>Enhancing regulatory enforcement, expanding e-health system participation, and improving policy processes are essential for the GoU to address challenges posed by private sector growth. Strengthening these governance mechanisms will support Ukraine’s goals of equity, financial protection, and high-quality care, enhancing resilience to the multiple impacts of the war.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"158 ","pages":"Article 105349"},"PeriodicalIF":3.6,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144071746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Munich goes viral: Measuring the impact of the Oktoberfest on COVID-19 infection rates using difference-in-differences 慕尼黑病毒：使用差异中的差异来衡量慕尼黑啤酒节对COVID-19感染率的影响

IF 3.6 3区医学

Health Policy Pub Date : 2025-05-12 DOI: 10.1016/j.healthpol.2025.105332

Daniel Herold , Phil-Adrian Klotz , Jan Thomas Schäfer

引用次数: 0

From clicks to care: Exploring the digital strategies of Italian health authorities in communicating ‘General Practitioner Selection’ service 从点击到护理：探索意大利卫生当局在沟通“全科医生选择”服务方面的数字战略

IF 3.6 3区医学

Health Policy Pub Date : 2025-05-10 DOI: 10.1016/j.healthpol.2025.105347

Alessandro Vinci , Luca Pirrotta , Giulia Venturi , Milena Vainieri

{"title":"From clicks to care: Exploring the digital strategies of Italian health authorities in communicating ‘General Practitioner Selection’ service","authors":"Alessandro Vinci , Luca Pirrotta , Giulia Venturi , Milena Vainieri","doi":"10.1016/j.healthpol.2025.105347","DOIUrl":"10.1016/j.healthpol.2025.105347","url":null,"abstract":"<div><div>The prioritization of digitalization is crucial to the agendas of nations worldwide. While substantial funds have been allocated to foster it, there remains a scarcity of tools dedicated to systematically monitoring the performance of the digital transformation. This work describes the level of digitalization and information of a fundamental primary care service: the “General Practitioner (GP) selection”. The analysis was conducted by consulting websites of Italian Local Health Authorities (LHAs). First, we explored the digitalization levels of 105 websites through the Primary Care Digital Information (PCDI) composite index. It comprises four dimensions: informativeness, accessibility, inclusiveness, and adaptability, scoring on a five-point scale (low-high digitalization). Second, we conducted a readability analysis, employing three validated measures. We found an average level of digitalization and information, although dimensions perform differently. The best-performing dimension was adaptability, while the worst was inclusiveness. Half of the LHAs provided several digital alternatives to GP selection, while the remaining provided limited or no options. Regarding readability, just 29% of the LHA's websites were found easy to read. Overall, our findings depict that Italian LHAs have different approaches. This study highlights that, despite best practices, several areas require monitoring and intervention. Moreover, some barriers characterize Italian health communication strategies, notably the variability of information across and within regions and on average low website readability.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"157 ","pages":"Article 105347"},"PeriodicalIF":3.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144068388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Price regulation and competition among on-patent anticancer drugs in Italy 意大利非专利抗癌药的价格调控与竞争

IF 3.6 3区医学

Health Policy Pub Date : 2025-05-08 DOI: 10.1016/j.healthpol.2025.105348

Michele Caimmi , Beatrice Canali , Laura Candelora , Alessandra Di Costanzo , Francesca Fiorentino , Chiara Vassallo , Maria Luisa Mancusi

{"title":"Price regulation and competition among on-patent anticancer drugs in Italy","authors":"Michele Caimmi , Beatrice Canali , Laura Candelora , Alessandra Di Costanzo , Francesca Fiorentino , Chiara Vassallo , Maria Luisa Mancusi","doi":"10.1016/j.healthpol.2025.105348","DOIUrl":"10.1016/j.healthpol.2025.105348","url":null,"abstract":"<div><div>In recent years, the Italian Medicines Agency has adopted several measures aimed at curbing public pharmaceutical expenditure, including temporary and confidential price reductions, and Managed Entry Agreements. Besides, the Agency plays a pivotal role in price negotiations, serving as a tool for cost containment and financial sustainability for the Italian NHS. Our study aims at testing one potentially relevant channel for pursuing this objective and analyze if the Agency anchors the treatment cost of on-patent market entrants with those of on-patent therapeutic alternatives that previously obtained reimbursement in a given market. Our sample includes 86 anticancer indications which obtained reimbursement in Italy between March 2017 and May 2022, whose marketing authorization was granted under the centralized procedure at European level. Gathering data from multiple sources (drugs Summary of Product Characteristics, their pivotal clinical trials, and an IQVIA database on Italian negotiation dynamics), we identify competing indications within cancer site and treatment line, and then evaluate treatment costs based on median exposure to treatment in pivotal clinical trials. We retrieve prices from hospital expenditure data, which reflect discount negotiated with the regulator, tender, and commercial discounts. Our findings suggest that both the market average and the last reimbursed treatment cost significantly correlate with newly negotiated treatment costs, indicating that earlier negotiation outcomes serve as benchmarks for new ones.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"157 ","pages":"Article 105348"},"PeriodicalIF":3.6,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144068302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Examining COVID-19 mortality inequalities across 169 countries: Insights from the COVID-19 mortality inequality curve (CMIC) and Theil index analysis 审视169个国家的COVID-19死亡率不平等：来自COVID-19死亡率不平等曲线（CMIC）和Theil指数分析的见解

IF 3.6 3区医学

Health Policy Pub Date : 2025-05-08 DOI: 10.1016/j.healthpol.2025.105345

Emiliano Lopez Barrera , Kristina Miljkovic , Kodjo Barnor , Dragan Miljkovic

{"title":"Examining COVID-19 mortality inequalities across 169 countries: Insights from the COVID-19 mortality inequality curve (CMIC) and Theil index analysis","authors":"Emiliano Lopez Barrera , Kristina Miljkovic , Kodjo Barnor , Dragan Miljkovic","doi":"10.1016/j.healthpol.2025.105345","DOIUrl":"10.1016/j.healthpol.2025.105345","url":null,"abstract":"<div><h3>Background</h3><div>The COVID-19 pandemic has highlighted global disparities in health outcomes, with mortality driven by pre-existing comorbidities, demographic vulnerabilities, and systemic socioeconomic inequalities. These factors underscore the need for evidence-based policies to address health inequities and strengthen system resilience.</div></div><div><h3>Objective</h3><div>This study quantifies COVID-19 mortality disparities across 169 countries, focusing on obesity, age, and income dimensions, to inform equitable and effective policy interventions.</div></div><div><h3>Methods</h3><div>Using publicly available datasets, the COVID-19 Mortality Inequality Curve (CMIC) and Index (CMII) were applied to measure disparities, while the Theil Index decomposed them into within- and between-group components. Mortality data were analyzed at three time points—December 2020, August 2021, and February 2022—to capture the effects of vaccination campaigns.</div></div><div><h3>Results</h3><div>The Theil Index revealed significant reductions in mortality inequality among countries with lower obesity rates (from 1.43 to 0.80) and older populations (from 0.95 to 0.54), reflecting the impact of targeted vaccination efforts. However, income-based disparities showed limited improvement (Theil Index: 0.61 to 0.54), emphasizing persistent inequities in healthcare access. High-income countries achieved the most significant reductions in inequality due to early and widespread vaccination.</div></div><div><h3>Conclusions</h3><div>Tailored health policies prioritizing equitable vaccine distribution, data harmonization, and targeted interventions for obesity and age-related vulnerabilities are critical for reducing disparities and strengthening health system resilience during global crises.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"157 ","pages":"Article 105345"},"PeriodicalIF":3.6,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143942255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The impact of C-level positions on hospital performance: A scoping review of top management team outcomes c级职位对医院绩效的影响：对最高管理团队成果的范围审查

IF 3.6 3区医学

Health Policy Pub Date : 2025-05-07 DOI: 10.1016/j.healthpol.2025.105346

Matthias Lukas Zuchowski , Dennis Henzler , Mark Dominik Alscher , Eckhard Nagel

{"title":"The impact of C-level positions on hospital performance: A scoping review of top management team outcomes","authors":"Matthias Lukas Zuchowski , Dennis Henzler , Mark Dominik Alscher , Eckhard Nagel","doi":"10.1016/j.healthpol.2025.105346","DOIUrl":"10.1016/j.healthpol.2025.105346","url":null,"abstract":"<div><h3>Background</h3><div>As hospitals expand their roles within transforming health systems, their governance structures must adapt to changing demands, with novel leadership structures evolving to meet new challenges.</div></div><div><h3>Objective</h3><div>This review aims to provide a comprehensive overview on the evidence of the influence of hospital C-level positions on key organisational performance parameters. It maps key concepts from the existing literature relating to hospital performance and leadership and identifies mediators and moderators of top management team impacts based on the Upper-Echelons-Theory.</div></div><div><h3>Methods</h3><div>The scoping review was conducted according to the Joanna Briggs Institute methodology and Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews, covering studies from 1990 to the present. Eligible studies addressed at least one identifiable hospital C-Suite role and one hospital-wide leadership effect.</div></div><div><h3>Results</h3><div>Out of 5430 articles identified, 60 were included. The analysis covers seven distinct C-Suite roles and their effects on six performance dimensions: quality of care, structural quality, patient satisfaction, work satisfaction, financial performance, and process efficiency.</div></div><div><h3>Conclusions</h3><div>The findings suggest that the influence of C-Suite positions on hospital performance is multifaceted, with the Chief Executive Officer’s influence extending beyond financial performance to shaping the quality of care. Additionally, the impact of newer roles such as the Chief Quality Officer, as well as leadership roles like the Chief Medical Officer and Chief Nursing Officer, appear to depend on a collaborative approach and alignment with the Chief Executive Officer. From a policy perspective, the findings emphasise that hospital governance, shaped by regulations, determines key performance indicators and strategic priorities.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"157 ","pages":"Article 105346"},"PeriodicalIF":3.6,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144068304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Understanding the influence of leadership, organisation, and policy on delivering an integrated child health and social care service in community settings: A qualitative exploration using the SELFIE framework. 了解领导力、组织和政策对在社区环境中提供综合儿童健康和社会护理服务的影响：使用自拍框架的定性探索。

IF 3.6 3区医学

Health Policy Pub Date : 2025-05-03 DOI: 10.1016/j.healthpol.2025.105335

I Litchfield, L Harper, M Syed, F Dutton, M Melyda, C Wolhuter, C Bird

{"title":"Understanding the influence of leadership, organisation, and policy on delivering an integrated child health and social care service in community settings: A qualitative exploration using the SELFIE framework.","authors":"I Litchfield, L Harper, M Syed, F Dutton, M Melyda, C Wolhuter, C Bird","doi":"10.1016/j.healthpol.2025.105335","DOIUrl":"https://doi.org/10.1016/j.healthpol.2025.105335","url":null,"abstract":"<p><strong>Background: </strong>The Sparkbrook Children's Zone is an example of a place-based integrated health and social care service developed to support children and young people living in marginalized populations in the United Kingdom. This model of care is expected to address both clinical need and the social determinants of health but evidence of the practical support needed is lacking.</p><p><strong>Objective: </strong>To understand the infrastructural challenges of providing a service combining clinical and non-clinical staff from a range of organisations and settings.</p><p><strong>Methods: </strong>A qualitative exploration of the experiences of staff delivering the service and used a directed content analysis to present the results within the Sustainable integrated chronic care model for multi-morbidity: delivery, financing, and performance (SELFIE) framework.</p><p><strong>Results: </strong>A total of 14 staff were interviewed including clinicians, social care providers, local voluntary groups, and school-based family mentors. Participants described the gap between system-level integration and the lack of practical support for delivering a unified service on the ground; the training opportunities afforded by collocation; the complexity of securing staff from multiple employers using various funding sources; and the need for lengthier evaluations that extend beyond early instability.</p><p><strong>Conclusions: </strong>Despite decades of structural reform aimed at integrating the health and social care system in the UK, there was a surprising lack of practicable support for delivering a place-based integrated health and social care service. Their delivery is also hindered by short-term funding cycles limiting the reliability of evidence gathered from complex and evolving services.</p>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":" ","pages":"105335"},"PeriodicalIF":3.6,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How do policy supports enable the implementation, scale, and sustainability of integrated care programs in England, Germany, and The Netherlands? Lessons for Canada. 在英国、德国和荷兰，政策支持如何促进综合护理项目的实施、规模和可持续性？给加拿大的教训。

IF 3.6 3区医学

Health Policy Pub Date : 2025-05-03 DOI: 10.1016/j.healthpol.2025.105334

Stefanie Tan, Julie Farmer, Walter P Wodchis, Sara Allin

{"title":"How do policy supports enable the implementation, scale, and sustainability of integrated care programs in England, Germany, and The Netherlands? Lessons for Canada.","authors":"Stefanie Tan, Julie Farmer, Walter P Wodchis, Sara Allin","doi":"10.1016/j.healthpol.2025.105334","DOIUrl":"https://doi.org/10.1016/j.healthpol.2025.105334","url":null,"abstract":"<p><strong>Background: </strong>Integrated care aims to coordinate the care needs of a population, particularly individuals requiring complex care, across community, primary and secondary care settings. This study explores policy supports for integrated models of care in England, Germany, and The Netherlands to consider the implications for policy transfer for Canada.</p><p><strong>Methods: </strong>We reviewed academic and grey literature about integrated models of care across three comparator countries and conducted in-depth qualitative interviews with 14 expert informants in Autumn 2023. Results were mapped against a framework for analysis about policy supports and transfer.</p><p><strong>Results: </strong>Integrated care initiatives varied in scale and scope with local population initiatives (Germany), devolved decision-making initiatives (England), or by addressing population subgroups (Netherlands). There are power and relative funding imbalances between the health and social services sectors that impede collaboration. Voluntary approaches to organisational governance reforms and partnerships with primary care providers promote uptake but policy entrepreneurs are crucial to facilitating implementation. Workforce adaptations and upskilling initiatives can enable interprofessional collaboration and intersectoral knowledge to address implementation gaps. There remain practical challenges with data infrastructure and sharing.</p><p><strong>Conclusions: </strong>Legislation is an important enabling factor for supporting governance. New financing streams can reward collaborative working for interdisciplinary teams. Policymakers at the macro- and meso‑level must support policy from intention to implementation.</p>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":" ","pages":"105334"},"PeriodicalIF":3.6,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Early access to medicines with added therapeutic value: Measuring and comparing time to medicines access in England, France, Germany, Italy and Spain 早期获得具有附加治疗价值的药物：衡量和比较英国、法国、德国、意大利和西班牙的药物获取时间

IF 3.6 3区医学

Health Policy Pub Date : 2025-04-28 DOI: 10.1016/j.healthpol.2025.105317

Sophie Delcroix-Lopes , Nadia Amer , Christophe Chaignot , Charlotte Pelletan

{"title":"Early access to medicines with added therapeutic value: Measuring and comparing time to medicines access in England, France, Germany, Italy and Spain","authors":"Sophie Delcroix-Lopes , Nadia Amer , Christophe Chaignot , Charlotte Pelletan","doi":"10.1016/j.healthpol.2025.105317","DOIUrl":"10.1016/j.healthpol.2025.105317","url":null,"abstract":"<div><div>The scientific breakthroughs over the past few decades have opened up new therapeutic possibilities, transforming the treatment of critical illnesses like cancer and rare diseases. However, delayed access to these innovations can lead to a loss of valuable life years for patients.</div><div>The annual European medicines access times Monitor, launched by the French Statutory Health Insurance (CNAM) with the support of the French National Authority for Health (HAS), analysed time to patient access across five countries between 2017 and 2023 (England, France, Germany, Italy and Spain) for a sample of 50 molecules that demonstrate therapeutic improvement.</div><div>The results underscore the crucial role of Early Access Schemes-EAS in accelerating patient access to medicines. These schemes are particularly prevalent in countries where national reimbursement is contingent on Health Technology Assessment-HTA assessments and price negotiations—notably France, Italy, and Spain.</div><div>These findings indicate that early access schemes, rather than being restricted to compassionate use for patients with no alternative treatment options, can also serve as a strategy to expedite access to essential therapies, particularly cancer drugs, prior to their formal reimbursement.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"157 ","pages":"Article 105317"},"PeriodicalIF":3.6,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143882893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The role of community pharmacists in natural disasters: Experiences from the 2023 Türkiye earthquakes 社区药师在自然灾害中的作用：来自2023年台湾地震的经验

IF 3.6 3区医学

Health Policy Pub Date : 2025-04-28 DOI: 10.1016/j.healthpol.2025.105333

Samet Dinçer , Fatma Gündüz , Ezgi Atalay , Galip Usta , Sare Peçe Göktaş

{"title":"The role of community pharmacists in natural disasters: Experiences from the 2023 Türkiye earthquakes","authors":"Samet Dinçer , Fatma Gündüz , Ezgi Atalay , Galip Usta , Sare Peçe Göktaş","doi":"10.1016/j.healthpol.2025.105333","DOIUrl":"10.1016/j.healthpol.2025.105333","url":null,"abstract":"<div><h3>Objective</h3><div>On 6 February 2023, a series of earthquakes struck the south-eastern region of Türkiye. The aim of this research is to identify the challenges and experiences of community pharmacists who were first-degree victims of the earthquake during and after the earthquake in providing health services.</div></div><div><h3>Methods</h3><div>Phenomenological design, one of the qualitative research methods, was used in the study. In-depth interviews were conducted with 15 individuals who were both first-degree earthquake victims and community pharmacists.</div></div><div><h3>Results</h3><div>Qualitative data were analyzed with the MAXQDA 2020 program and three main themes were created. It was determined that community pharmacists did not prepare despite knowing about seismic hazards. Following the disaster, a number of difficulties arose, such as drug safety issues, risky behaviors, and the physical destruction of pharmacies. It was noted that some community pharmacists could not return to normal processes on the date of the research.</div></div><div><h3>Conclusions</h3><div>Continuing pharmacy services without interruption during disasters is of global importance. Before the disaster, training should be organized for community pharmacists on their roles in disasters, medication management, and providing health care. Community pharmacists should take part in crisis management committees and contribute to drug supply chain planning. The roles of community pharmacists in risk reduction, preparedness, response, and recovery phases should be determined, and strategic actions should be developed for pre- and post-disaster periods.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"157 ","pages":"Article 105333"},"PeriodicalIF":3.6,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143899889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0